ARVINAS ($ARVN) posted quarterly earnings results for Q2 2026 on Tuesday, August 4th. The company reported earnings of $2.58 per share, beating estimates of -$0.38 by $2.96. The company also reported revenue of $249,700,000, beating estimates of $33,192,840 by $216,507,160.
You can see Quiver Quantitative's $ARVN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ARVINAS Insider Trading Activity
ARVINAS insiders have traded $ARVN stock on the open market 23 times in the past 6 months. Of those trades, 1 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $ARVN stock by insiders over the last 6 months:
- JOHN G HOUSTON has made 0 purchases and 3 sales selling 35,297 shares for an estimated $466,153.
- BRIGGS MORRISON purchased 20,000 shares for an estimated $268,070
- NOAH BERKOWITZ (Chief Medical Officer) has made 0 purchases and 3 sales selling 23,228 shares for an estimated $249,410.
- RANDY TEEL (President and CEO) has made 0 purchases and 5 sales selling 21,055 shares for an estimated $226,476.
- ANDREW SAIK (Chief Financial Officer) has made 0 purchases and 3 sales selling 21,969 shares for an estimated $218,209.
- ANGELA M CACACE (Chief Scientific Officer) has made 0 purchases and 5 sales selling 20,434 shares for an estimated $214,014.
- DAVID K LOOMIS (VP, Chief Accounting Officer) has made 0 purchases and 3 sales selling 4,043 shares for an estimated $44,623.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ARVINAS Hedge Fund Activity
We have seen 80 institutional investors add shares of ARVINAS stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 2,085,554 shares (-90.1%) from their portfolio in Q1 2026, for an estimated $22,106,872
- JACOBS LEVY EQUITY MANAGEMENT, INC added 1,189,227 shares (+471.4%) to their portfolio in Q1 2026, for an estimated $12,605,806
- VESTAL POINT CAPITAL, LP added 905,465 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,597,929
- TWO SIGMA INVESTMENTS, LP added 839,651 shares (+84.6%) to their portfolio in Q1 2026, for an estimated $8,900,300
- CITADEL ADVISORS LLC added 767,342 shares (+185.5%) to their portfolio in Q1 2026, for an estimated $8,133,825
- MILLENNIUM MANAGEMENT LLC removed 683,089 shares (-54.2%) from their portfolio in Q1 2026, for an estimated $7,240,743
- BLACKROCK, INC. removed 524,917 shares (-7.2%) from their portfolio in Q1 2026, for an estimated $5,564,120
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ARVINAS Price Targets
Multiple analysts have issued price targets for $ARVN recently. We have seen 7 analysts offer price targets for $ARVN in the last 6 months, with a median target of $19.0.
Here are some recent targets:
- Sudan Loganathan from Stephens & Co. set a target price of $18.0 on 06/03/2026
- Jeet Mukherjee from BTIG set a target price of $18.0 on 05/13/2026
- Etzer Darout from Barclays set a target price of $20.0 on 05/13/2026
- Yigal Nochomovitz from Citigroup set a target price of $24.0 on 05/04/2026
- Jonathan Miller from Evercore ISI Group set a target price of $19.0 on 02/25/2026
- Robert Driscoll from Wedbush set a target price of $11.0 on 02/25/2026
- Edward Tenthoff from Piper Sandler set a target price of $20.0 on 02/25/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
